[1] Li Q, Huang P, Zheng C, et al. Prognostic significance of p53 immunohistochemical expression in adenoid cystic carcinoma of the salivary glands: a meta-analysis[J]. Oncotarget, 2017, 8(17):29458-29473.
[2] Dantas AN, Morais EF, Macedo RA, et al. Clinicopathological characteristics and perineural invasion in adenoid cystic carcinoma: a systematic review [J]. Braz J Otorhinolaryngol, 2015, 81(3):329-335.
[3] Otsu K, Harada H. Rho GTPases in ameloblast differentiation[J]. Jpn Dent Sci Rev, 2016, 52(2):32-40.
[4] Hetmanski JH, Schwartz JM, Caswell PT. Modelling GTPase dynamics to understand RhoA-driven cancer cell invasion[J]. Biochem Soc Trans, 2016, 44(6):1695-1700.
[5] Cai Q, Zhang R, Wu G, et al. Adenoid cystic carcinoma of submandibular salivary gland with late metastases to lung and choroid: a case report and literature review[J]. J Oral Maxillofac Surg, 2014, 72(9):1744-1755.
[6] Wysocki PT, Izumchenko E, Meir J, et al. Adenoid cystic carcinoma: emerging role of translocations and gene fusions[J]. Oncotarget, 2016, 7(40):66239-66254.
[7] Watzlawick R, Sena ES, Dirnagl U, et al. Effect and reporting bias of RhoA/ROCK-blockade intervention on locomotor recovery after spinal cord injury: a systematic review and meta-analysis[J]. JAMA Neurol, 2014, 71(1):91-99.
[8] Jeong D, Park S, Kim H, et al. RhoA is associated with invasion and poor prognosis in colorectal cancer[J]. Int J Oncol, 2016, 48(2):714-722.
[9] 廖山婴, 刘超, 王蓓蓓, 等. RhoA/ROCK信号通路在胃癌中的表达及其与胃癌生物学行为的关系[J]. 胃肠病学和肝病学杂志, 2017, 26(3):251-255.
[10] 胡威, 董忠谊, 吴德华. FAT10通过激活RhoA介导肝细胞性肝癌侵袭转移[J]. 中国肿瘤临床, 2015, 42(14):689-694.
[11] Timpson P, McGhee EJ, Morton JP, et al. Spatial regulation of RhoA activity during pancreatic cancer cell invasion driven by mutant p53[J]. Cancer Res, 2011, 71(3):747-757.
[12] 严国鑫, 樊兵, 邹荣海, 等. 沉默RohA基因对舌鳞状细胞癌细胞增殖的影响[J]. 华西口腔医学杂志, 2016, 34(6):620-625. |